Progressive Multiple Sclerosis

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)

Obe-cel in Refractory Progressive Forms of Multiple Sclerosis

Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis

Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) Patients

A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple Sclerosis

Study of Circadian Focused Light Therapy in Progressive Multiple Sclerosis

Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS)

RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis

Serum Neurofilaments and GFAP in Atypical Multiple Sclerosis

Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis

ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis

A Study of Oxidative Pathways in MS Fatigue

ABA-101 in Participants With Progressive Multiple Sclerosis

Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis

Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS)

Effect of Variance on Error Correction During Coupling

Effects of Transcranial Static Magnetic Field Stimulation (tSMS) in Progressive Multiple Sclerosis

Telerehabilitation in Progressive Multiple Sclerosis

Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis

Multiple Sclerosis Prediction and Monitoring of Progression Study